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Better understanding of how hematopoietic stem cells
(HSCs) balance self-renewal and diﬀerentiation is vital for
their application in treatment of various diseases and regen-
erative medicine. During the last decade tremendous ad-
vances have been made in identifying a complex network
of cellular and molecular factors that inﬂuence self-renewal
and diﬀerentiation of HSCs and characterizing the cellular
and molecular components of niches which harbor HSCs.
Improving our understanding of the cellular and molecular
mechanisms that regulate self-renewal and diﬀerentiation of
HSCs will have a profound impact on experimental and
clinical HSCs research and clinical application of HSCs.
Thus, Stem Cells International set out to publish a special
issue devoted to the topic of heterogeneity, self-renewal, and
diﬀerentiation of hematopoietic stem cells.
The ongoing research is continuously increasing our
knowledge about HSC niches in the bone marrow and in
particular about cell types constituting niches and a plethora
of molecules and signals that make up the synapse between
HSCs and niche cells. A series of three review articles in this
issue discuss the role of hematopoietic niches in regulating
behavior and function of hematopoietic stem cells and the
role of niches in development of leukemias.
K. S. Tieu et al. present a review of quantitative ap-
proaches to understanding stem cell niche signaling in the
hematopoietic system, as well as in other tissues under con-
ditions of homeostasis and carcinogenesis. They explain the
beneﬁts of mathematical models in advancing our under-
standing of the mechanisms that regulate stem cell fate and
how this regulation changes in cancer development. K. S.
Tieu and colleagues are also highlighting the synergistic rela-
tionship between mathematical predictions and experimen-
tal validation and address the potential for mathematical
models to predict and optimize therapies targeting the stem
cell niche.
In their review “Osteoblastic and vascular endothelial
niches, their control on normal hematopoietic stem cells, and
their consequences on the development of leukemia”B .S .
Guerrouahen and colleagues provide some common cellular
and molecular principles applying to the osteoblastic and
vascular hematopoietic niches and discuss altered microen-
vironment signaling leading to myeloid lineage disease. They
also review the emerging evidence for the role of microen-
vironment in supporting the leukemia-initiating cells (LICs)
and the inﬂuence of the microenvironment on chemother-
apy resistance.
The two predominant niches in the bone marrow, the
endosteal and vascular niches, are thought to regulate the
self-renewal and diﬀerentiation of distinct HSC populations,
and also dictate HSC behavior with respect to homeostatic
requirements and exogenous stresses. In their review article
“The Haematopoietic stem cell niche: new insights into the
mechanisms regulating haematopoietic stem cell behaviour”A .
J. Lilly and colleagues discuss recent research into the cellular2 Stem Cells International
and molecular components of endosteal and vascular niches.
Taking into account the crosstalk and overlap between cell
types and signaling in these two niches, J. Lilly et al. propose
that endosteal and vascular niches should be viewed as
subcompartmentsofasingleHSCniche.ThereviewbyH.C.
O’Neill et al. from Australia focuses on the spleen microen-
vironment as a site of development of novel dendritic-like
cells which are phenotypically and functionally distinct from
other described antigen-presenting cells. The discovery that
the lineage origin and the progenitors for this new type of
tissue-speciﬁc antigen-presenting cells diﬀer from that of
other known dendritic and myeloid cell types suggests that
spleen represents a distinct microenvironment for develop-
ment of a novel myeloid cell type arising from HSCs or pro-
genitors endogenous to spleen. This paper also highlights the
need to explore in more detail the contribution of the spleen
and its microenvironment to steady-state hematopoiesis.
β-Thalassemia is characterized by reduction or absence
of β-globin production, resulting in anemia. Current thera-
piesincludebloodtransfusioncombinedwithironchelation,
BMtransplantationwhichisrestrictedbythematcheddonor
limitation, and gene therapy with β-globin lentiviral vectors.
The review by E. Drakopoulou et al. presents the current
status of gene therapy for β-thalassemia, its success and limi-
tations, and the novel promising strategies available involv-
ing the therapeutic role of HSCs. This paper reviews achieve-
ments in improving vector safety and eﬃciency to stably
transduce HSCs, while minimizing insertional mutagenesis.
The authors also discuss strategies that result in higher num-
bers of genetically modiﬁed HSCs, including manipulation
of the ex vivo HSC culture conditions, use of mobilized
HSC, and generation of HSCs from patient-speciﬁc induced
pluripotent stem (iPS) cells. These novel strategies could set
the ground for more successful β-thalassemia gene therapy
clinical trials.
The papers in this special issue highlight both the
advancements and challenges in understanding the role of
niches in HSC biology and fate and in the use of HSCs in
disease treatment.
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